Unity Biotechnology's 2023 Cash, Cash Equivalents And Marketable Securities Of $43.2M Is Expected To Fund Operations Into Q3 Of 2025
Unity Biotechnology's 2023 Cash, Cash Equivalents And Marketable Securities Of $43.2M Is Expected To Fund Operations Into Q3 Of 2025
Unity Biotechnology的2023年现金、现金等价物和有价证券的4,320万美元预计将为2025年第三季度的运营提供资金
Unity Biotechnology's 2023 Cash, Cash Equivalents And Marketable Securities Of $43.2M Is Expected To Fund Operations Into Q3 Of 2025
Unity Biotechnology的2023年现金、现金等价物和有价证券的4,320万美元预计将为2025年第三季度的运营提供资金
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。